Q1: What area of law does Enright v. Eli Lilly & Co. primarily address?
Torts
Q2: What was the central legal issue in Enright v. Eli Lilly & Co.?
Does New York recognize a third-generation (preconception) tort claim by a child whose injuries are alleged to result from her mother's in utero exposure to DES caused by the grandmother's ingestion of the drug decades earlier?
Q3: What rule did the court apply?
In New York, a defendant generally owes no duty of care to individuals not yet conceived at the time of the alleged negligent conduct; thus, preconception tort claims by a later-born child are not cognizable absent legislative authorization. While New York recognizes market-share liability for DES daughters directly exposed in utero (Hymowitz v. Eli Lilly & Co.), that doctrine does not create a duty where none exists and does not extend to third-generation claims.
Q4: What was the court's holding?
No. The Court of Appeals held that the infant plaintiff's third-generation claim is not cognizable as a matter of New York law. Although the mother may pursue claims for her own DES-related injuries, the child's claim for injuries allegedly resulting from her mother's in utero exposure is barred because New York does not recognize preconception tort claims by a later-born child.
Q5: Why is Enright v. Eli Lilly & Co. significant?
Enright defines the outer boundary of DES liability in New York: it preserves claims by DES daughters while rejecting third-generation claims by DES granddaughters. For law students, the case is a touchstone on the duty/foreseeability divide, demonstrating how courts use duty as a policy lever to contain potentially limitless liability despite scientific foreseeability. It also clarifies the relationship between substantive duty rules and procedural/proof doctrines like market-share liability—showing that evidentiary innovations cannot expand the class of rightful plaintiffs. Beyond DES, Enright is frequently cited in preconception tort cases and in debates over whether tort law should redress harms to persons not yet in existence when the defendant acted. It illustrates judicial institutional competence concerns and deference to legislatures in areas with complex social, scientific, and economic ramifications.